These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


269 related items for PubMed ID: 7921389

  • 1. Effect of recombinant tissue plasminogen activator on intra-abdominal abscess formation in rats with generalized peritonitis.
    van Goor H, de Graaf JS, Kooi K, Sluiter WJ, Bom VJ, van der Meer J, Bleichrodt RP.
    J Am Coll Surg; 1994 Oct; 179(4):407-11. PubMed ID: 7921389
    [Abstract] [Full Text] [Related]

  • 2. Gentamycin reduces bacteremia and mortality rates associated with the treatment of experimental peritonitis with recombinant tissue plasminogen activator.
    van Goor H, de Graaf JS, Kooi K, Bleichrodt RP.
    J Am Coll Surg; 1995 Jul; 181(1):38-42. PubMed ID: 7599769
    [Abstract] [Full Text] [Related]

  • 3. Prevention of intra-abdominal abscesses with fibrinolytic agents.
    Rosenthal GA, Quinto J, Kao J, Rotstein OD.
    Can J Surg; 1988 Mar; 31(2):98-100. PubMed ID: 3127033
    [Abstract] [Full Text] [Related]

  • 4. Both tissue-type plasminogen activator and urokinase prevent intraabdominal abscess formation after surgical treatment of peritonitis in the rat.
    Buyne OR, van Goor H, Bleichrodt RP, Verweij PE, Hendriks T.
    Surgery; 2008 Jul; 144(1):66-73. PubMed ID: 18571586
    [Abstract] [Full Text] [Related]

  • 5. Timing and dose of tissue plasminogen activator to prevent abscess formation after surgical treatment of secondary peritonitis in the rat.
    Buyne OR, van Goor H, Verweij PE, Bleichrodt RP, Hendriks T.
    Surg Innov; 2009 Dec; 16(4):299-305. PubMed ID: 20031941
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prevention of intra-abdominal abscesses by fibrinolysis using recombinant tissue plasminogen activator.
    Rotstein OD, Kao J.
    J Infect Dis; 1988 Oct; 158(4):766-72. PubMed ID: 3139778
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tissue-type plasminogen activator prevents formation of intra-abdominal abscesses after surgical treatment of secondary peritonitis in a rat model.
    Buyne OR, Bleichrodt RP, van Goor H, Verweij PE, Hendriks T.
    Int J Colorectal Dis; 2007 Jul; 22(7):819-25. PubMed ID: 17089129
    [Abstract] [Full Text] [Related]

  • 11. Effects of intra-abdominal administration of recombinant tissue plasminogen activator on coagulation, fibrinolysis and inflammatory responses in experimental polymicrobial peritonitis.
    van Veen SQ, Meijers JC, Levi M, van Gulik TM, Boermeester MA.
    Shock; 2007 May; 27(5):534-41. PubMed ID: 17438459
    [Abstract] [Full Text] [Related]

  • 12. Development of Candida albicans and C. albicans/Escherichia coli/Bacteroides fragilis intraperitoneal abscess models with demonstration of fungus-induced bacterial translocation.
    Sawyer RG, Adams RB, May AK, Rosenlof LK, Pruett TL.
    J Med Vet Mycol; 1995 May; 33(1):49-52. PubMed ID: 7650578
    [Abstract] [Full Text] [Related]

  • 13. Polysaccharide-mediated protection against abscess formation in experimental intra-abdominal sepsis.
    Tzianabos AO, Kasper DL, Cisneros RL, Smith RS, Onderdonk AB.
    J Clin Invest; 1995 Dec; 96(6):2727-31. PubMed ID: 8675640
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Auto-cross-linked hyaluronic acid gel does not reduce intra-abdominal adhesions or abscess formation in a rat model of peritonitis.
    Sikkink CJ, de Man B, Bleichrodt RP, van Goor H.
    J Surg Res; 2006 Dec; 136(2):255-9. PubMed ID: 17059836
    [Abstract] [Full Text] [Related]

  • 18. Tissue-type plasminogen activator prevents abscess formation but does not affect healing of bowel anastomoses and laparotomy wounds in rats with secondary peritonitis.
    Buyne OR, Bleichrodt RP, De Man BM, Lomme RM, Verweij PE, van Goor H, Hendriks T.
    Surgery; 2009 Nov; 146(5):939-46. PubMed ID: 19744456
    [Abstract] [Full Text] [Related]

  • 19. Diffusion-, T2-, and perfusion-weighted nuclear magnetic resonance imaging of middle cerebral artery embolic stroke and recombinant tissue plasminogen activator intervention in the rat.
    Jiang Q, Zhang RL, Zhang ZG, Ewing JR, Divine GW, Chopp M.
    J Cereb Blood Flow Metab; 1998 Jul; 18(7):758-67. PubMed ID: 9663506
    [Abstract] [Full Text] [Related]

  • 20. The role of plasminogen activator in adhesion prevention.
    Menzies D, Ellis H.
    Surg Gynecol Obstet; 1991 May; 172(5):362-6. PubMed ID: 1902993
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.